Medicare Enrolled
Dr. Manuel Cunanan, M.D.
Critical Care Medicine · Millville, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cunanan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cunanan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cunanan
Dr. Manuel Cunanan is a critical care medicine specialist in Millville, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Cunanan performed 4,517 Medicare services across 3,282 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cunanan received a total of $255,668 from 50 pharmaceutical and/or device companies across 1339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cunanan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 6% volume in NJ
$255,668 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,517
Medicare services
Top 6% in NJ for critical care medicine
3,282
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~266 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
948 | $102 | $204 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
528 | $33 | $120 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
528 | $51 | $80 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
527 | $28 | $80 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
527 | $38 | $95 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
374 | $72 | $152 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
250 | $131 | $250 |
| Home sleep study test with type II portable monitor An unattended sleep study performed at home using a portable monitor that records at least seven channels, including brain activity, eye movement, muscle activity, heart rate, airflow, breathing effort, and oxygen levels. |
114 | $95 | $350 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
112 | $54 | $135 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
100 | $42 | $110 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
100 | $34 | $100 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
83 | $41 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
56 | $12 | $145 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
54 | $61 | $150 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
46 | $16 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
40 | $140 | $260 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
40 | $17 | $75 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
34 | $116 | $290 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
30 | $45 | $120 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
26 | $30 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$255,668
Total received (2018-2024)
Avg $36,524/year across 7 years
Top 1% in NJ for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,339
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$242,749 (94.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,920 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$153,659
2023
$58,313
2022
$18,295
2021
$12,498
2020
$4,934
2019
$1,398
2018
$6,572
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$138,940
Grifols USA, LLC
$6,828
Optinose US, Inc.
$6,003
GlaxoSmithKline, LLC.
$699
Regeneron Healthcare Solutions, Inc.
$252
GENZYME CORPORATION
$195
Philips North America LLC
$171
Mylan Specialty L.P.
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Amgen Inc.
$66
Avadel CNS Pharmaceuticals, LLC
$51
Insmed, Inc.
$45
Mallinckrodt Hospital Products Inc.
$45
Resmed Corp
$40
ANI Pharmaceuticals, Inc.
$39
Inspire Medical Systems, Inc.
$36
Electromed, Inc.
$19
HARMONY BIOSCIENCES LLC
$14
Top 3 companies account for 98.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$219,391
Grifols USA, LLC
$12,513
Optinose US, Inc.
$6,062
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,453
GlaxoSmithKline, LLC.
$2,882
Philips Electronics North America Corporation
$1,158
GENZYME CORPORATION
$1,109
Grifols Shared Services North America, Inc.
$1,080
Regeneron Healthcare Solutions, Inc.
$945
Mylan Specialty L.P.
$715
Mallinckrodt Hospital Products Inc.
$436
Amgen Inc.
$411
Insmed, Inc.
$293
Tulsa Dental Products LLC
$261
Sunovion Pharmaceuticals Inc.
$255
Harmony Biosciences LLC
$236
Genentech USA, Inc.
$221
ANI Pharmaceuticals, Inc.
$194
Philips North America LLC
$171
Electromed, Inc.
$149
Actelion Pharmaceuticals US, Inc.
$145
Covis Pharma GmBH
$140
Advanced Respiratory, Inc
$136
Novartis Pharmaceuticals Corporation
$112
QOL Medical, LLC
$105
JAZZ PHARMACEUTICALS INC.
$83
Baxter Healthcare
$73
Masimo Corporation
$71
Gilead Sciences, Inc.
$70
United Therapeutics Corporation
$67
Ethicon Inc.
$64
Merck Sharp & Dohme Corporation
$63
Mallinckrodt Enterprises LLC
$53
Avadel CNS Pharmaceuticals, LLC
$51
Allergan Inc.
$46
Bayer HealthCare Pharmaceuticals Inc.
$43
HARMONY BIOSCIENCES LLC
$42
Teva Pharmaceuticals USA, Inc.
$41
Resmed Corp
$40
Mallinckrodt LLC
$36
Inspire Medical Systems, Inc.
$36
Evoke Pharma, Inc.
$32
Exeltis, USA Inc.
$30
CSL Behring
$30
Jazz Pharmaceuticals Inc.
$27
Allergan, Inc.
$25
Paratek Pharmaceuticals, Inc.
$23
Circassia Pharmaceuticals Inc
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
ADVANCED RESPIRATORY, INC
$14
Top 3 companies account for 93.1% of all-time payments
Associated products mentioned in payments ›
(4939) Cough Assist Access · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BROVANA · CINQAIR · DALIRESP · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · Endodontic Dentistry · Esbriet · FARXIGA · FASENRA · GIMOTI · Hillrom - Life 2000 Ventilation System · INSPIRE · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · Monarch Platform · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PCMS Und · PURIFIED CORTROPHIN GEL · Perforomist · Personal Care Undiv · Prolastin-C · Prolastin-C Liquid · S&RC Und · SET and rainbow SET · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUCRAID · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Utibron · Veklury · WAKIX · Wakix · Wellcentive Undiv · XIFAXAN · XOLAIR · Xembify · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for critical care medicine in NJ.
Geographic Context
Critical care medicines within 10 mi
6
Per 100K population
3.9
County median income
$64,499
Nearest hospital
INSPIRA MEDICAL CENTER VINELAND
8.8 mi
8.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cunanan is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NJ), with speaking/promotional industry engagement in the top 1% of NJ peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cunanan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cunanan performed 948 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cunanan receive payments from pharmaceutical companies?
Yes. Dr. Cunanan received a total of $255,668 from 50 companies across 1,339 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cunanan's costs compare to other critical care medicines in Millville?
Dr. Cunanan's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cunanan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Millville
Browse critical care medicines in Millville ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in NJ
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in NJ
Which NJ critical care medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Grifols USA, LLC Payments to Doctors
See all physicians who received payments from Grifols USA, LLC.
By company
Optinose US, Inc. Payments to Doctors
See all physicians who received payments from Optinose US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology